May 02, 2017
New York recently expanded its medical marijuana program by adding chronic pain, but there is an important group of patients who are still left out — those who suffer from post-traumatic stress disorder (PTSD). Twenty-four of the 29 states with medical marijuana programs allow patients with PTSD to qualify, but New York still does not. A 7006 and S 5629 would change that; please ask your legislators to support these bills.
Last week, the Assembly Health Committee voted unanimously to approve A 7006, and it now heads to the Assembly floor.
There are only two drugs that are FDA-approved to treat PTSD, and neither has been shown to be more effective than a placebo. Both of these drugs, and others commonly prescribed “off-label,” have dangerous side effects that cannabis does not. Many veterans — including an estimated 20% of those who served in Iraq — suffer from PTSD, which leads to the tragically high suicide rate among returning veterans. Shouldn't those who have served our country have access to any treatment that might help ease their suffering?